News · CRL (Complete Response Letter)
67 stories
2dFDA’s complete response letter for Summit’s ivonescimab cites China-heavy data beyond survival miss
Sep 21, 26Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition